Acadia Healthcare Company Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Acadia Healthcare Company wird ein jährliches Gewinn- und Umsatzwachstum von 42.7% bzw. 9.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 41.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11% betragen.
Wichtige Informationen
42.7%
Wachstumsrate der Gewinne
41.6%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 17.1% |
| Wachstumsrate der Einnahmen | 9.3% |
| Zukünftige Eigenkapitalrendite | 11.0% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 18 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Is Acadia Healthcare Company (NASDAQ:ACHC) Using Too Much Debt?
Jun 16
Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Shareholders Might Be Looking For Exit
May 24Acadia Healthcare: M&A Strategies Facilitate Market Expansion
May 03The Return Trends At Acadia Healthcare Company (NASDAQ:ACHC) Look Promising
Mar 21Acadia Healthcare Company (NASDAQ:ACHC) Seems To Use Debt Quite Sensibly
Feb 12Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Not Quite Adding Up
Dec 27We Like These Underlying Return On Capital Trends At Acadia Healthcare Company (NASDAQ:ACHC)
Dec 06What Does Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Indicate?
Oct 23These 4 Measures Indicate That Acadia Healthcare Company (NASDAQ:ACHC) Is Using Debt Reasonably Well
Sep 13Acadia Healthcare Company (NASDAQ:ACHC) Is Experiencing Growth In Returns On Capital
Aug 23Do Acadia Healthcare Company's (NASDAQ:ACHC) Earnings Warrant Your Attention?
Jul 24Is There Now An Opportunity In Acadia Healthcare Company, Inc. (NASDAQ:ACHC)?
Jul 10Is Acadia Healthcare Company (NASDAQ:ACHC) A Risky Investment?
May 29Returns On Capital Are Showing Encouraging Signs At Acadia Healthcare Company (NASDAQ:ACHC)
May 15With EPS Growth And More, Acadia Healthcare Company (NASDAQ:ACHC) Makes An Interesting Case
Apr 16What Is Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Doing?
Apr 03We Think Acadia Healthcare Company (NASDAQ:ACHC) Can Stay On Top Of Its Debt
Feb 19Acadia Healthcare Company (NASDAQ:ACHC) Is Experiencing Growth In Returns On Capital
Feb 05With EPS Growth And More, Acadia Healthcare Company (NASDAQ:ACHC) Makes An Interesting Case
Jan 08When Should You Buy Acadia Healthcare Company, Inc. (NASDAQ:ACHC)?
Dec 26Is Acadia Healthcare Company (NASDAQ:ACHC) A Risky Investment?
Nov 16Returns At Acadia Healthcare Company (NASDAQ:ACHC) Are On The Way Up
Oct 24Here's Why We Think Acadia Healthcare Company (NASDAQ:ACHC) Is Well Worth Watching
Sep 28What Is Acadia Healthcare Company, Inc.'s (NASDAQ:ACHC) Share Price Doing?
Sep 14We Think Acadia Healthcare Company (NASDAQ:ACHC) Can Stay On Top Of Its Debt
Aug 17Acadia Healthcare Q2 2022 Earnings Preview
Jul 26Investors Met With Slowing Returns on Capital At Acadia Healthcare Company (NASDAQ:ACHC)
Jul 25Acadia Healthcare: Capitalizing On Major Mental Health Trend
Jul 19If EPS Growth Is Important To You, Acadia Healthcare Company (NASDAQ:ACHC) Presents An Opportunity
Jun 27At US$68.23, Is Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Worth Looking At Closely?
Jun 12A Look At The Fair Value Of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)
May 19Acadia Healthcare Company (NASDAQ:ACHC) Seems To Use Debt Quite Sensibly
May 07The Returns At Acadia Healthcare Company (NASDAQ:ACHC) Aren't Growing
Apr 25Do Acadia Healthcare Company's (NASDAQ:ACHC) Earnings Warrant Your Attention?
Mar 29Is It Too Late To Consider Buying Acadia Healthcare Company, Inc. (NASDAQ:ACHC)?
Mar 02An Intrinsic Calculation For Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Suggests It's 47% Undervalued
Feb 15Is Acadia Healthcare Company (NASDAQ:ACHC) Using Too Much Debt?
Jan 16Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 3,892 | 421 | N/A | N/A | 6 |
| 12/31/2025 | 3,526 | 365 | 63 | 611 | 11 |
| 12/31/2024 | 3,198 | 321 | -18 | 144 | 11 |
| 3/31/2024 | 2,993 | -11 | -403 | 97 | N/A |
| 12/31/2023 | 2,929 | -22 | 38 | 462 | N/A |
| 9/30/2023 | 2,861 | -18 | 87 | 460 | N/A |
| 6/30/2023 | 2,778 | 271 | 42 | 363 | N/A |
| 3/31/2023 | 2,698 | 278 | 36 | 348 | N/A |
| 12/31/2022 | 2,610 | 273 | 84 | 381 | N/A |
| 9/30/2022 | 2,529 | 282 | 68 | 365 | N/A |
| 6/30/2022 | 2,449 | 277 | 170 | 434 | N/A |
| 3/31/2022 | 2,380 | 242 | 139 | 375 | N/A |
| 12/31/2021 | 2,314 | 203 | 130 | 374 | N/A |
| 9/30/2021 | 2,262 | 192 | 250 | 463 | N/A |
| 6/30/2021 | 2,223 | 162 | 337 | 560 | N/A |
| 3/31/2021 | 2,132 | 144 | 464 | 689 | N/A |
| 12/31/2020 | 2,090 | 140 | 434 | 659 | N/A |
| 9/30/2020 | 1,230 | 14 | 400 | 592 | N/A |
| 6/30/2020 | 1,459 | 20 | 269 | 469 | N/A |
| 3/31/2020 | 1,757 | 41 | 121 | 335 | N/A |
| 12/31/2019 | 2,008 | 52 | 100 | 333 | N/A |
| 9/30/2019 | 3,071 | -211 | 47 | 341 | N/A |
| 6/30/2019 | 3,054 | -208 | 6 | 325 | N/A |
| 3/31/2019 | 3,031 | -197 | 45 | 385 | N/A |
| 12/31/2018 | 1,905 | 57 | 161 | 414 | N/A |
| 9/30/2018 | 2,993 | 226 | 84 | 414 | N/A |
| 6/30/2018 | 2,949 | 225 | 111 | 429 | N/A |
| 3/31/2018 | 2,899 | 216 | 121 | 415 | N/A |
| 12/31/2017 | 2,836 | 200 | N/A | 400 | N/A |
| 9/30/2017 | 2,815 | 172 | N/A | 373 | N/A |
| 6/30/2017 | 2,833 | 9 | N/A | 366 | N/A |
| 3/31/2017 | 2,873 | 15 | N/A | 360 | N/A |
| 12/31/2016 | 2,811 | 6 | N/A | 361 | N/A |
| 9/30/2016 | 2,603 | -1 | N/A | 358 | N/A |
| 6/30/2016 | 2,348 | 146 | N/A | 332 | N/A |
| 3/31/2016 | 2,046 | 124 | N/A | 281 | N/A |
| 12/31/2015 | 1,794 | 112 | N/A | 240 | N/A |
| 9/30/2015 | 1,594 | 100 | N/A | 188 | N/A |
| 6/30/2015 | 1,409 | 96 | N/A | 177 | N/A |
| 3/31/2015 | 1,169 | 85 | N/A | 126 | N/A |
| 12/31/2014 | 1,005 | 83 | N/A | 115 | N/A |
| 9/30/2014 | 900 | 73 | N/A | 88 | N/A |
| 6/30/2014 | 790 | 62 | N/A | 66 | N/A |
| 3/31/2014 | 754 | 52 | N/A | 72 | N/A |
| 12/31/2013 | 713 | 43 | N/A | 66 | N/A |
| 9/30/2013 | 638 | 35 | N/A | 57 | N/A |
| 6/30/2013 | 556 | 27 | N/A | 53 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: ACHC wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.4%).
Ertrag vs. Markt: ACHC wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: ACHC wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: ACHCDie Einnahmen des Unternehmens (9.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: ACHCDie Einnahmen des Unternehmens (9.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: ACHCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11%).